Warfarin Induced Coagulopathy (Warfarin Over-Anticoagulation)
Normal Vitamin K Cycle
Vitamin K is required for γ-carboxylation of:
- Factors II, VII, IX, X
- Protein C
- Protein S
Vitamin K is recycled by:Vitamin K epoxide reductase (VKORC1)
Warfarin inhibits VKORC1.Factor VII falls first—>PT/INR rises within 24–36 hours.Maximum anticoagulant effect:≈ 5 days
Causes of Warfarin-Induced Coagulopathy
1. Excess Dose
Most common cause.
Examples:Wrong prescription,Medication error,Intentional overdose
2. Drug Interactions
|
Drugs Decreasing INR |
Drugs Increasing INR |
|
Rifampicin |
Amiodarone, Metronidazole, TMP-SMX, Fluconazole |
|
Carbamazepine |
Broad-spectrum antibiotics |
|
Phenytoin |
Valproate |
|
St John’s Wort |
Macrolides |
3. Reduced Vitamin K Intake
- Starvation,Malnutrition,NPO status,Elderly patients
4. Liver Disease
Reduced synthesis of clotting factors.
Even therapeutic warfarin doses can produce severe INR elevation.
5. Heart Failure
Congestive hepatopathy decreases warfarin metabolism.
6. Acute Illness
- Sepsis,Fever,Hyperthyroidism Increase warfarin sensitivity.
Clinical Presentation
Minor Bleeding
- Epistaxis
- Gingival bleeding
- Easy bruising
- Menorrhagia
Moderate Bleeding
- Hematuria
- GI bleeding
- Large ecchymoses
Major Bleeding
Defined by criteria such as:
- Fatal bleeding
- Symptomatic bleeding in critical organ
- Hb drop ≥2 g/dL
- Transfusion ≥2 units PRBC
Differential Diagnosis
|
Condition |
Difference |
|
DIC |
Low fibrinogen, thrombocytopenia |
|
Liver failure |
Multiple abnormalities |
|
DOAC overdose |
PT/INR less reliable |
|
Factor deficiency |
Specific factor abnormality |
Reversal of Warfarin Coagulopathy(ASH 2018 and ACCP 2012 guidelines)
|
INR |
Bleeding Risk |
Warfarin |
Vitamin K |
4F-PCC (Beriplex/Kcentra) |
|
< 4.5 |
Any |
Reduce dose or omit next dose |
Not required |
Not required |
|
4.5 – 10 |
Low |
Hold/omit warfarin(INR check 24 hours) |
Not routinely recommended |
Not required |
|
4.5 – 10 |
High |
Hold/omit warfarin(INR check 24 hours) |
1–2 mg POOR 0.5–1 mg IV ?? |
Not required |
|
> 10 |
Low |
Stop warfarin(INR check 12-24 hours) |
3–5 mg PO or IV |
Not required |
|
> 10 |
High |
Stop warfarin(INR check 12-24 hours) |
3–5 mg PO or IV |
15–30 IU/kg(consider if urgent reversal needed) |
|
Any INR |
Emergency surgery required (no active bleeding) |
Stop warfarin(INR check 30–60 min after PCC) |
5–10 mg IV |
25–50 IU/kg |
|
Any INR |
Life-threatening bleeding develops |
Stop warfarin(INR check 30–60 min after PCC), |
10 mg IV,Tranexamic acid |
25–50 IU/kg immediately,hematologist or toxicologist should be consulted. |
Definition of HIGH Bleeding Risk
Any of the following:
|
High-Risk Feature |
|
Age >75 years |
|
Previous GI bleed |
|
Previous intracranial hemorrhage |
|
Dual antiplatelet therapy |
|
CKD stage 4–5 |
|
Liver disease |
|
Malignancy |
|
Uncontrolled hypertension |
|
Frequent falls/frailty |
|
Recent surgery |
|
Thrombocytopenia |
- There is no reason to prophylactically administer vitamin K and it is associated with increased length of stay and false reassurrance of normalization of INR, as the duration of action of warfarin is much longer than vitamin K.
- Activated charcoal can be considered in patients who are awake and alert and present within 1 hour of ingestion.
- It is not recommended that patients without bleeding receive FFP or Prothrombin Complex Concentrate (PCC)
Fresh Frozen Plasma (FFP)
Contains all coagulation factors.
Dose-10–15 mL/kg
Prothrombin Complex Concentrate (PCC)
Preferred therapy.
Contains:Factors II,VII,IX,X
Four-factor PCC is preferred.
PCC Dose (AHA/ACCP Recommendations)
|
INR |
PCC Dose |
|
2–4 |
25 U/kg |
|
4–6 |
35 U/kg |
|
>6 |
50 U/kg |
Maximum:5000 units
Always combine with:Vitamin K 10 mg IV
Why PCC + Vitamin K?
PCC provides immediate clotting factors.But PCC effect lasts: 6–8 hours.Vitamin K restores endogenous synthesis. Without vitamin K:INR rebounds.
Restarting Anticoagulation(TIMING CONTROVERSIAL)
Depends on indication and bleed site.
|
Situation |
Restart |
|
Minor bleed |
1–3 days |
|
GI bleed |
7–14 days |
|
Mechanical valve |
Earlier (often 3–7 days) |
|
ICH |
Usually 2–8 weeks depending on risk |
Individualize based on thrombotic versus bleeding risk.
REFERENCES
- Deaton JG, Nappe TM. Warfarin Toxicity. [Updated 2023 Jul 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431112/
- Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y, Guyatt G. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893. PMID: 30482765; PMCID: PMC6258922.
- Jain H, Singh G, Kaul V, Gambhir HS. Management dilemmas in restarting anticoagulation after gastrointestinal bleeding. Proc (Bayl Univ Med Cent). 2022 Mar 9;35(3):322-327. doi: 10.1080/08998280.2022.2043707. PMID: 35518826; PMCID: PMC9037438.